HEAL-X: A Novel Classification System for Xylazine Associated Wounds

Area of Science:

• Veterinary Medicine
• Dermatology
• Public Health

Background:

• Xylazine, a veterinary sedative, is increasingly found in illicit drug supplies, contributing to the opioid crisis.
• Xylazine use leads to severe skin wounds, posing significant morbidity risks.
• Existing wound classification systems are inadequate for xylazine-associated injuries.

Purpose of the Study:

• To develop and introduce the HEAL-X classification system for standardizing the assessment and treatment of xylazine-associated wounds.
• To provide a tailored approach for managing the unique pathology of xylazine-induced skin lesions.

Main Methods:

• An inter-disciplinary panel developed the HEAL-X system.
• The system grades wounds from 0 to 5 based on History, Extent, Appearance, Location, and Xylazine-specific features.
• HEAL-X integrates existing classification principles with xylazine-specific pathology.

Main Results:

• The HEAL-X system offers a standardized framework for grading xylazine-associated wounds.
• It guides treatment decisions from less severe to critical wound presentations.
• The system addresses a critical gap in managing these complex wounds.

Conclusions:

• HEAL-X provides a novel, tailored approach to managing xylazine-associated wounds, improving upon existing models.
• The system requires empirical validation through clinical application and further research.
• HEAL-X is poised to enhance patient outcomes in the context of rising xylazine use.